VEGFR-2 kinase inhibitors (Kunming Pharmaceutical)

N/A

Report date: 2025/01/26 17:40:23
NME

Base Information

Drug NameVEGFR-2 kinase inhibitors (Kunming Pharmaceutical)
Drug Alias NameKYAH01-2020-139
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKpc Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesKpc Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A